Description
“GLP-3” is a popular shorthand for Reta***tide, a next-generation “triple agonist” peptide that targets GLP-1, GIP, and glucagon receptors simultaneously. By adding the glucagon receptor to traditional GLP-1 therapies, it actively boosts resting metabolic rate and liver fat burning alongside powerful appetite suppression. In clinical trials, this triple-action mechanism has achieved unprecedented weight loss results, averaging upwards of 24% to 28% body weight reduction.
Reviews
There are no reviews yet.